Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2015 Nov;39(7):532-6.
doi: 10.1053/j.semperi.2015.08.007. Epub 2015 Sep 8.

Pharmacologic studies in vulnerable populations: Using the pediatric experience

Kanecia Zimmerman  1 , Daniel Gonzalez  2 , Geeta K Swamy  3 , Michael Cohen-Wolkowiez  4
Affiliations
Review

Pharmacologic studies in vulnerable populations: Using the pediatric experience

Kanecia Zimmerman et al. Semin Perinatol. 2015 Nov.

Abstract

Historically, few data exist to guide dosing in children and pregnant women. Multiple barriers to inclusion of these vulnerable populations in clinical trials have led to this paucity of data. However, federal legislation targeted at pediatric therapeutics, innovative clinical trial design, use of quantitative clinical pharmacology methods, pediatric thought leadership, and collaboration have successfully overcome many existing barriers. This success has resulted in improved knowledge on pharmacokinetics, safety, and efficacy of therapeutics in children. To date, research in pregnant women has not been characterized by similar success. Wide gaps in knowledge remain despite the common use of therapeutics in pregnancy. Given the similar barriers to drug research and development in pediatric and pregnant populations, the route toward success in children may serve as a model for the advancement of drug development and appropriate drug administration in pregnant women.

Keywords: children; drug development; drug trials; pregnancy.

PubMed Disclaimer

References

    1. Herring C, McManus A, Weeks A. Off-label prescribing during pregnancy in the UK: an analysis of 18,000 prescriptions in Liverpool Women’s Hospital. Int J Pharm Pract. 2010 Aug;18(4):226–229. - PubMed
    1. Blehar MC, Spong C, Grady C, Goldkind SF, Sahin L, Clayton JA. Enrolling pregnant women: issues in clinical research. Womens Health Issues. 2013 Jan;23(1):e39–45. - PMC - PubMed
    1. Anger GJ, Piquette-Miller M. Pharmacokinetic studies in pregnant women. Clin Pharmacol Ther. 2008 Jan;83(1):184–187. - PubMed
    1. Shanks NGR, Greek J. Are animal models predictive for humans? Philos Ethics Humanit Med. 2009;15(4) - PMC - PubMed
    1. National Institutes of Health [Accessed March 3, 2015];National Institutes of Health Revitalization Act of 1993. Accessed via: http://orwh.od.nih.gov/about/pdf/NIH-Revitalization-Act-1993.pdf.

Publication types